AbCellera Biologics Inc. (ABCL): Price and Financial Metrics
ABCL Price/Volume Stats
| Current price | $2.67 | 52-week high | $6.05 |
| Prev. close | $2.71 | 52-week low | $2.34 |
| Day low | $2.62 | Volume | 1,719,600 |
| Day high | $2.72 | Avg. volume | 1,696,815 |
| 50-day MA | $2.68 | Dividend yield | N/A |
| 200-day MA | $3.46 | Market Cap | 788.63M |
ABCL Stock Price Chart Interactive Chart >
AbCellera Biologics Inc. (ABCL) Company Bio
AbCellera focuses on therapeutic antibodies, screening, choosing, and analyzing millions of naturally produced antibodies to be used as next-generation drug candidates. It specializes in the fields of biotechnology, medicine, and therapeutics. It was founded in 2012 and headquartered in Vancouver, British Columbia.
ABCL Price Returns
| 1-mo | -5.99% |
| 3-mo | 2.30% |
| 6-mo | -30.65% |
| 1-year | -39.73% |
| 3-year | -81.48% |
| 5-year | N/A |
| YTD | -53.24% |
| 2023 | -43.63% |
| 2022 | -29.16% |
| 2021 | -64.46% |
| 2020 | N/A |
| 2019 | N/A |
Loading social stream, please wait...